What is PHARM.AS's gross margin?

Pharming (PHARM.AS) has a gross margin of 84% and a net margin of 2%.

What is PHARM.AS's P/E ratio?

PHARM.AS's P/E ratio is 66.6 with ROE of 4%.

Where can I see PHARM.AS's full financials?

See Pharming (PHARM.AS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Pharming (PHARM.AS) Financials — Revenue, Earnings, Cash Flow

Also trades as: PHAR (NASDAQ) · $vol 0M · PHGUF (OTC) · $vol 0M

€0.87 ($0.98)

-0.02 (-1.76%)

Weekly Expected Move ±4.6%

€1 €1 €1 €1 €1

AMS · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · €615.9M mcap · 703M float · 1.28% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

€366M

Revenue

+7.7% YoY

€9M

Net Income

+214.7% YoY

€31M

Free Cash Flow

+1.4% YoY

83.9%

Gross Margin

2.2%

Op. Margin

1.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE3.8%

ROA2.1%

ROIC3.8%

Valuation

P/E66.6

P/B2.7

EV/EBITDA0.0

Leverage

Debt/Equity0.49

Current Ratio3.01

Interest Cov.0.0x

Quality Scores

Piotroski F7/9

Altman Z—

Beneish M-2.56